Tumor resistance to CD8+T cell-based therapeutic vaccination
✍ Scribed by Yujun Huang; Shivanee Shah; Liang Qiao
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 141 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0004-069X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract A major objective of peptide vaccination is the induction of tumor‐reactive CD8^+^ T‐cells. We have shown that HLA‐A2 positive cancer patients frequently develop an antigen‐specific CD8^+^ T‐cell response after vaccination with NY‐ESO‐1 peptides p157‐165/p157‐167. These T‐cells are high
## Abstract Generation of antigen‐specific CD8+ T cell responses is considered optimal for an effective immunotherapy against cancer. In this study, we provide a proof of principle that __in vitro__ observed diminished CD8+ T cell response provided a strong __in vivo__ tumor protection. Immunizatio
## Abstract Though TGF‐β inhibition enhances antitumor immunity mediated by CD8^+^ T cells in several tumor models, it is not always sufficient for rejection of tumors. In this study, to maximize the antitumor effect of TGF‐β blockade, we tested the effect of anti‐TGF‐β combined with an irradiated
The goal of therapeutic vaccination is to elicit an antiviral immune response within persistently infected individuals and consequently eradicate the infection. CD8+ T cells are potent mediators of viral clearance; however, during chronic infections CD4+ T cell help is required to sustain antiviral